Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 19.

Journal Article

Baues, C. M., Semrau, R., Nast-Kolb, B. and Eich, H. T. (2014). Role of radiotherapy in Hodgkin's lymphoma. Onkologe, 20 (5). S. 441 - 447. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Broeckelmann, P. J., Goergen, H., Fuchs, M., Eich, H. T., Stein, H., Diehl, V., Borchmann, P. and Engert, A. (2016). Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: Experience of the German Hodgkin Study Group (GHSG). Oncol. Res. Treat., 39. S. 122 - 123. BASEL: KARGER. ISSN 2296-5262

Channaoui, M., Oertel, M., Kroeger, K., Baues, C., Haverkamp, U. and Eich, H. T. (2020). Investigation of the Dose Parameters as a Part of the Quality Assurance for the Hodgkin Study (HD17) and its Consequences on the Tumor Control Rate and the Rate of Side Effects. Strahlenther. Onkol., 196 (SUPPL 1). S. S166 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Eich, H. T., Kriz, J., Engenhart-Cabillic, R., Haverkamp, U., Herfarth, K., Lukas, P., Schmidberger, H., Staar, S., Pluetschow, A., Fuchs, M., Engert, A. and Baues, C. (2016). FINAL RESULTS OF A QUALITY ASSURANCE PROGRAM WITHIN THE GERMAN HODGKIN STUDY GROUP HD13/14 TRIAL - A REPORT FROM THE RADIOTHERAPY REFERENCE PANEL INTEGRATING MODERN GUIDELINES. Haematologica, 101. S. 14 - 15. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Eich, H. T., Kriz, J., Klimm, B., Sasse, S., Goergen, H., Diehl, V., Borchmann, P., Mueller, R. and Engert, A. (2012). Involved-field (IF) Versus Extended-field (EF) Radiation Therapy (RT) for Patients in Early Unfavorable Stages of Hodgkin Lymphoma: 10-year Update of the HD8 Trial of the German Hodgkin Study Group (GHSG). Int. J. Radiat. Oncol. Biol. Phys., 84 (3). S. S70 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 0360-3016

Eich, H. T., Kriz, J., Reinartz, G., Kobe, C., Kuhnert, G., Haverkamp, U., Haverkamp, H., Hegerfeld, K., Baues, C. and Engert, A. (2013). Relapse Analysis After Radiation Therapy of PET-Positive Residual Tumors of Patients With Advanced Stage Hodgkin Lymphoma Treated in the HD15 Trial of the German Hodgkin Study Group (GHSG). Int. J. Radiat. Oncol. Biol. Phys., 87 (2). S. S5 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X

Engert, A., Eich, H. T. and Hoffken, K. (2018). Hodgkin's Lymphoma - new Horizons. Onkologe, 24 (4). S. 278 - 280. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Gazarin, A., Moustakis, C., Stoeber, U., Eich, H. T. and Haverkamp, U. (2018). Examining the Image Quality of Cone Beam Computed Tomography. Strahlenther. Onkol., 194. S. S154 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Hay, A. E., Klimm, B., Chen, B. E., Goergen, H., Shepherd, L. E., Fuchs, M., Gospodarowicz, M. K., Borchmann, P., Connors, J. M., Markova, J., Crump, M., Lohri, A., Winter, J. N., Doerken, B., Pearcey, R. G., Diehl, V., Horning, S. J., Eich, H. T., Engert, A. and Meyer, R. M. (2013). An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. Ann. Oncol., 24 (12). S. 3065 - 3070. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Klimm, B., Goergen, H., Fuchs, M., von Tresckow, B., Boell, B., Meissner, J., Glunz, A., Diehl, V., Eich, H. T., Engert, A. and Borchmann, P. (2013). Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitions. Ann. Oncol., 24 (12). S. 3070 - 3077. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Kobe, C., Dietlein, M., Borchmann, P., Engert, A., Kuhnert, G., Fuchs, M., Haverkamp, H., Eich, H. T., Kriz, J. and Diehl, V. (2011). PET-Response Adapted Therapy in Hodgkin Lymphoma. Eur. J. Cancer, 47. S. S16 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 0959-8049

Kobe, C., Goergen, H., Fuchs, M., Eich, H. T., Baues, C., Diehl, V., Kuhnert, G., Drzezga, A., Dietlein, M., Engert, A. and Borchmann, P. (2017). Treatment Reduction in Patients with Advanced-Stage Hodgkin Lymphoma and Negative Interim FDG-PET: Final Results of the International, Randomized, Phase 3 HD18 Trial by the German Hodgkin Study Group. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S312 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

Kriz, J., Baues, C., Engenhart-Cabillic, R., Haverkamp, U., Herfart, K., Lukas, P., Pluetschow, A., Schmidberger, H., Staar, S., Fuchs, M., Engert, A. and Eich, H. T. (2017). Quality control of involved field radiotherapy in the HD 13 and HD 14 trials. Strahlenther. Onkol., 193 (2). S. 109 - 116. MUNICH: URBAN & VOGEL. ISSN 1439-099X

Kriz, J., Baues, C., Engenhart-Cabillic, R., Haverkamp, U., Herfarth, K., Lukas, P., Schmidberger, H., Marnitz-Schulze, S., Fuchs, M., Engert, A. and Eich, H. T. (2017). New quality assurance program integrating modern radiotherapy within the German Hodgkin Study Group. Strahlenther. Onkol., 193 (2). S. 100 - 109. MUNICH: URBAN & VOGEL. ISSN 1439-099X

Kriz, J., Mueller, R. -P., Mueller, H., Kuhnert, G., Engert, A., Kobe, C., Haverkamp, U. and Eich, H. T. (2012). Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma Is the definition on the basis of a chest radiograph in the era of CT obsolete? Strahlenther. Onkol., 188 (11). S. 1020 - 1025. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Moustakis, C., Blanck, O., Andratschke, N., Boda-Heggemann, J., Wilke, L., Tanadini-Lang, S., Albers, D., Alraun, M., Baeumer, C., Beckers, E., Blaschek, M., Brunner, T., Chan, M. K. H., Dierl, M., Droege, S., Duma, M-N., Ebrahimi, F., Eich, H. T., Fleckenstein, J., Ganswindt, U., Garbe, S., Gkika, E., Heinz, C., Henkenberens, C., Hennig, A., Henning, S., Koehn, J., Kornhuber, C., Kretschmer, M., Krieger, T., Loufti-Kraus, B., Mayr, M., Mensing, T., Pfeiler, T., Pollul, G., Ramm, U., Rieken, S., Roeder, F., Schmidthalter, D., Schmitt, D., Schoeffler, J., Ulm, C., Walke, M., Weigel, R., Wiehle, R., Wiezorek, T., Wolf, U., Zimmer, J., Baus, W. and Guckenberger, M. (2018). Reference of Plan Comparison Study for Liver-SBRT - Results DEGRO AG/DGMP AK Stereotaxis. Strahlenther. Onkol., 194. S. S18 - 2. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Oertel, M., Elsayad, K., Engenhart-Cabillic, R., Reinartz, G., Baues, C., Schmidberger, H., Vordermark, D., Marnitz, S., Lukas, P., Ruebe, C., Engert, A., Lenz, G. and Eich, H. T. (2020). Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance. Strahlenther. Onkol., 196 (12). S. 1096 - 1103. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Sasse, S., Broeckelmann, P. J., Baues, C., Eich, H. T. and Engert, A. (2018). Treatment of early stage Hodgkin lymphoma. Discussion of current trials and treatment recommendations. Onkologe, 24 (4). S. 303 - 315. NEW YORK: SPRINGER. ISSN 1433-0415

Sasse, S., Klimm, B., Goergen, H., Fuchs, M., Heyden-Honerkamp, A., Lohri, A., Koch, O., Wilhelm, M., Trenn, G., Finke, J., Mueller, R. P., Diehl, V., Eich, H. T., Borchmann, P. and Engert, A. (2012). Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma. Ann. Oncol., 23 (11). S. 2953 - 2960. OXFORD: OXFORD UNIV PRESS. ISSN 0923-7534

This list was generated on Sat May 21 03:23:42 2022 CEST.